Clinical Trial Update: The Specific Role of Isoflavones in Reducing Prostate Cancer Risk [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating whether isoflavones can reduce the risk of developing prostate cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Isoflavones (isoflavones)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED